Online Business

Natco Pharma launches anti-swine flu drug, Natflu

Drug maker Natco Pharma today said it has launched anti-swine flu drug Natflu. - Novartis" swine flu vaccine show encouraging results - SC to hear Novartis case next week - FDC closes buy-back offer; promoters" stake rises to 65.76% - Dr Reddy"s launches skin care product Strea Professional - Taro Q2 profit down 4% to $12.49 mn - Daiichi Sankyo posts Q1 loss of 6.43 bn yen "Natco Pharma has launched Natflu capsule, the cure for swine flu," the Hyderabad-based firm said in a statement. The maximum retail price for the medicine is fixed at Rs 480 for a bottle of 10 capsules and is available in all licensed pharmacies, it further said. Natflu is the generic version of Tamiflu-Oseltamivir.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Aban Offshore slumps 8% on sharp drop in net
Aban Offshore slumped over 8% to Rs 1,130 on the back of 65% decline in net profit.
Popular Articles
fast payday loans

India to start building 20 km roads per day by April: Nath
Road Transport and Highways Minister Kamal Nath said here that India had increased its per-day construction of roads to 9 km and the target of developing 20 km daily would be accomplished by April.“We have reached 9 km per day of road construction and will hit our target of 20 km a day by April,” Nath, who was here to hold talks with the Malaysian government to invite them to enter the highway construction sector in India, said.Thirty-five Malaysian companies are already involved with various infrastructure projects in India.To construct 20 km of raods a day or 7,000 km a year, there had to be 20,000 km of work in progress, he said.

India Inc's staff cost grew slower in Q4 of last fiscal
India Inc"s staff cost went up by 11.2 per cent during January-March last fiscal growing at a lesser pace than the previous three quarters of 2008-09, reflecting the economic slowdown, according to a Reserve Bank of India (RBI) study.